Join Zoom Meeting
https://mc-meet.zoom.us/j/95861380114?pwd=WThqQ2ZxM1l5SlVVV1lWNUN4WTl0UT09

Meeting ID: 958 6138 0114
Passcode: 188969

Neuro-Immunology
Eoin Flanagan, M.B., B.Ch.
"Update on Diagnosis and Treatment of MOG Antibody-Associated Disease (MOGAD)"

Learning objectives: 
Upon conclusion of this activity, participants will be able to:

• Recognize the novel clinical syndrome of cerebral cortical encephalitis in MOGAD
• Identify the spectrum of clinical and radiologic features in MOGAD
• Describe the current therapeutic approach in MOGAD

Dr. Flanagan does have the following relevant financial relationships to disclose: Consulting – Pharmacy Times, UpToDate and Grant/Research Support – NIH (R01NS113828), UCB and does intend to discuss the following off-label/investigative use of Pharmaceuticals or Instruments: Products – IVIg, Corticosteroids, Tocilzumab. Mycophenolate Mofetil, Rituximab; Manufacturer Roche – Satralizumab and Manufacturer UCB – ROZANOLIXZUMAB.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.